This is a routine employee share issuance with immaterial dilution. No trading action warranted. Monitor for any future material filings such as earnings or pipeline updates.
AZN drugs
AZN drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Jun 1 $179.55entry
- T+1 · 6mo ago −1.20%α −1.35% · $177.39
- T+5 · 5mo ago +3.57%α +6.32% · $185.95
- T+20 · 5mo ago +6.35%α +8.66% · $190.95
- T+60 · 3mo ago −5.55%α −6.52% · $169.59
Price Chart
How similar events traded
Executive Summary
AstraZeneca filed a 6-K reporting the admission of 14,120 ordinary shares to trading on the London Stock Exchange, issued under an existing employee share scheme block admission from January 2021. This is a routine administrative filing with no material financial or strategic impact.
Key Facts
- 14,120 ordinary shares of $0.25 each were admitted to trading on the London Stock Exchange Main Market.
- Total shares in issue post-admission: 1,551,009,750.
- Shares were issued under an existing block admission dated 29 January 2021 for employee share schemes.
- The admission covers shares issued between 1 May 2026 and 31 May 2026.
- No prospectus or supplementary prospectus was filed.
Financial Impact
Dilution from 14,120 new shares is negligible, approximately 0.0009% of total shares outstanding.
Risk Factors
- No material risks identified from this filing.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001654954-26-005587 |
| Document: 0001654954-26-005587-index-headers.html | 0001654954-26-005587 |
| Document: 0001654954-26-005587-index.html | 0001654954-26-005587 |
| Document: 0001654954-26-005587.txt | 0001654954-26-005587 |
Track record
77 reports on AZN
19 of 38 bullish or bearish reports moved the stock their way by T+5. Best: +20.72% at T+60 after the Aug 17, 2026 report. 29 of 38 went positive at some point.
Filters
- Nov 16, 2026today 6-K Bullish 6/10 Entry price pending
- Nov 16, 2026today 6-K Bullish 6/10 Entry $185.55 Now $184.02 −0.82% settles Nov 23
- Nov 16, 2026today 6-K Bullish 6/10 Entry $185.31 Now $184.02 −0.70% settles Nov 23
- Nov 16, 2026today 6-K Bullish 5/10 Entry $185.09 Now $184.02 −0.58% settles Nov 23
- Nov 4, 202611d ago Institutional Cluster Mixed 3/10 Entry $186.85 to $184.38 Now $184.02 −1.51% ▼ −1.32% −4.61% vs SPY
- Nov 2, 202614d ago 6-K Neutral 1/10 Entry $186.58 to $189.39 Now $184.02 −1.37% ▲ +1.51% +1.43% vs SPY
- Nov 2, 202614d ago 6-K Neutral 1/10 Entry $186.58 to $189.39 Now $184.02 −1.37% ▲ +1.51% +1.43% vs SPY
- Oct 30, 202617d ago 6-K Neutral 5/10 Entry $186.65 to $186.43 Now $184.02 −1.41% ▼ −0.12% +2.59% vs SPY
- Oct 27, 202620d ago 6-K Bullish 5/10 Entry $170.08 to $183.88 Now $184.02 +8.20% ▲ +8.11% +10.10% vs SPY
- Oct 22, 202625d ago 6-K Bullish 6/10 Entry $172.57 to $173.46 Now $184.02 +6.63% ▲ +0.51% −0.19% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers